PolitiFact @PolitiFact
The FDA revoked two monoclonal antibody drugs because they are ineffective against omicron, which makes up nearly all of COVID-19 cases in the U.S. today. There are multiple other therapies that are approved that work for both delta and omicron patients. https://t.co/AzIcXnFoRc — PolitiTweet.org